anmelden
OMX Copenhagen 20
1.544,40
PKT
+5,93
PKT
+0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 19.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 12.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.07.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.07.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 02.07.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.07.24 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
| 28.06.24 | Novo Nordisk Neutral | UBS AG | |
| 27.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 27.06.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 25.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 24.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 14.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 30.05.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 28.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 15.05.24 | Novo Nordisk Neutral | UBS AG | |
| 14.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 14.05.24 | Novo Nordisk Neutral | UBS AG | |
| 08.05.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.05.24 | Novo Nordisk Overweight | Barclays Capital | |
| 06.05.24 | Novo Nordisk Neutral | UBS AG | |
| 03.05.24 | Novo Nordisk Halten | DZ BANK | |
| 03.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.05.24 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 03.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | Novo Nordisk Overweight | Barclays Capital | |
| 02.05.24 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 02.05.24 | Novo Nordisk Neutral | UBS AG | |
| 02.05.24 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
| 02.05.24 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
| 02.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.04.24 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG |